Régression d’un thrombus cave néoplasique sous traitement par sorafénib

Autor:	Hassane Izzedine, Marc-Olivier Bitker, V. Sultan, O. Rixe, Frederic Thibault, B. Billemont, S. Bart
Rok vydání:	2008
Předmět:	Nephrology medicine.medical_specialty business.industry Urology medicine.medical_treatment medicine.disease Nephrectomy Surgery Venous thrombosis Internal medicine cardiovascular system medicine cardiovascular diseases Thrombus Venae cavae business Kidney cancer Dialysis Kidney disease
Zdroj:	Progrès en Urologie. 18:480-482
ISSN:	1166-7087
DOI:	10.1016/j.purol.2008.04.018
Popis:	Ten percent of patients with kidney cancer have associated vena cava thrombus, which is associated with a high operative morbidity. Up to now, no medical treatment has allowed regression of vena cava tumour thrombus. The authors report the case of a 62-year-old patient with left kidney cancer associated with vena cava tumour thrombus. After surgical resection, the patient relapsed in the form of vena cava thrombus associated with right renal vein thrombus, responsible for renal insufficiency requiring dialysis. Sorafenib therapy allowed regression of the vena cava thrombus, suspension of haemodialysis and local disease control with a follow-up of one year. This case report justifies a review of the place of anti-angiogenic therapy in the treatment of kidney cancer.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b91c67acfc21726f6a6437ad4ee50998 https://doi.org/10.1016/j.purol.2008.04.018 Zobrazit plný text záznamu